课题基金 / 基金详情

Effect of Exercise and Weight Loss on Cardiovascular Health

Effect of Exercise and Weight Loss on Cardiovascular Health
运动和减肥对心血管健康的影响
批准号:
8183827
负责人:
John M Jakicic
金额:
$75.52万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-01 至 2016-05-31

项目摘要

项目成果

John M Jakicic的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):这项研究的主要目的是在综合行为减肥计划的背景下,检验普遍的公共卫生推荐的体力活动水平[中等体力活动(MOD-PA)=150分钟/周]与较高剂量的体力活动[高体力活动(HIGH-PA)=250分钟/周]的影响,该计划包括利用心脏MRI和血管疾病风险的生物标记物减少心血管功能的能量摄入量。这些运动剂量中的每一个都将独立地与仅限饮食的小组干预所提出的主要和次要结果进行比较,MOD-PA也与高PA进行比较。这项研究招募了390名超重和肥胖的成年人,他们将被随机分配到上述条件之一(仅限饮食,MOD-PA,HIGH-PA),为期12个月。将在参与干预之前、干预最初6个月之后和干预12个月结束时对初级和次要结果进行基线评估。主要结果是心脏MRI测量的LVM。次要结果包括额外的心脏MRI测量(主动脉脉搏波速度、舒张末容量、主动脉扩张性)、炎症标记物(CRP和TNF1)和选定的脂肪细胞因子(脂联素),作为与血管结果、体重、身体成分和心肺健康相关的风险生物标记物,以及传统的心血管危险因素(血脂、葡萄糖、胰岛素、血压)。额外的二级分析将允许检查与体重变化无关的体力活动对主要和次要结果的影响。 与公共健康相关:据估计,超过65%的美国成年人超重或肥胖。特别重要的是超重和心血管疾病之间的联系。体力活动已被确定为改善长期减肥的重要组成部分。然而,体育活动的剂量,再加上减肥能量摄入的减少,导致最佳减肥效果的体育活动剂量可能与显著改善心血管健康的体育活动剂量不同。这项研究的数据将使研究人员能够更清楚地定义超重和肥胖成年人的推荐体力活动剂量,从而在全面减肥干预的背景下优化具有临床意义的心血管结果的改善。这些结果将提供重要的信息,这些信息将影响公众对体育锻炼的建议。
英文摘要
DESCRIPTION (provided by applicant): The primary aim of this study is to examine the effect of the consensus public health recommended level of physical activity [moderate physical activity (MOD-PA) = 150 min/wk] versus a higher dose of physical activity [high physical activity (HIGH-PA) = 250 min/wk] in the context of a comprehensive behavioral weight loss program that a includes a reduction in energy intake measures of cardiovascular function using cardiac MRI and biomarkers of vascular disease risk. Each of these exercise doses will be compared independently to a Diet Only group intervention on the proposed primary and secondary outcomes, with MOD-PA also compared to HIGH-PA. This study involves the recruitment of 390 overweight and obese adults who will be randomly assigned to one of the above conditions (Diet Only, MOD-PA, HIGH-PA) for a period of 12 months. Assessment of the primary and secondary outcomes will occur at baseline prior to participation in the intervention, following the initial six months of the intervention, and at the conclusion of 12 months of the intervention. The primary outcome is LVM measured by cardiac MRI. Secondary outcomes include additional cardiac MRI measures (aortic pulse wave velocity, end diastolic volume, aortic distensibility), inflammatory markers (CRP and TNF1) and selected adipocytokines (adiponectin) as biomarkers of risk related to vascular outcomes, body weight, body composition, and cardiorespiratory fitness, and traditional CVD risk factors (lipids, glucose, insulin, blood pressure). Additional secondary analyses will allow for examination of the effects of physical activity independent of weight change on the primary and secondary outcomes. PUBLIC HEALTH RELEVANCE: It is estimated that in excess of 65 percent of adults in the United States are overweight or obese. Of particular importance is the link between excess body weight and cardiovascular disease. Physical activity has been identified as an important component for improving long-term weight loss. However, the dose of physical activity, when coupled with a reduction in energy intake for weight loss, that results in the best weight loss may be different than the dose of physical activity that results in significant improvements in cardiovascular health. Data from this study will allow the investigators to more clearly define the recommended dose of physical activity for overweight and obese adults that optimizes improvements in clinically meaningful cardiovascular outcomes within the context of a comprehensive weight loss intervention. These results will provide important information that will influence public health recommendations for physical activity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Transducers of Physical Activity Clinical Centers (U01) - Pittsburgh Adult Clinical Center
Molecular Transducers of Physical Activity Clinical Centers (U01) - Pittsburgh Adult Clinical Center
Effect of Exercise and Weight Loss on Cardiovascular Health
Effect of Exercise and Weight Loss on Cardiovascular Health
海外基金